Bnp Paribas Arbitrage, Snc »

Lenz Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-06-30 $285k 17k 17.29
2024-03-31 $362k 16k 22.33

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Amazon.com Equity (AMZN)
Meta Platforms Equity (META)
iShares Russell 2000 ETF Fund (IWM)
Tesla Equity (TSLA)
Visa Equity (V)
Alphabet Equity (GOOGL)
Broadcom Equity (AVGO)
Alphabet Equity (GOOG)
SPDR S&P 500 ETF Trust Fund (SPY)
Costco Wholesale Corp Equity (COST)
Exxon Mobil Corp Equity (XOM)
Industrial Select Sector SPDR Fund Fund (XLI)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
BlackRock
Vanguard Group
Point72 Asset Management
Tang Capital Management
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Ikarian Capital
Board of Trustees of The Leland Stanford Junior University
Wealth Enhancement Advisory Services

View all funds holding Lenz Therapeutics